Active Clinical Trials

LIBERATE: The Eclipse™ System for Accidental Bowel Leakage


Are you a woman experiencing loss of bowel control?  The LIBERATE Study may be right for you!


Accidental Bowel Leakage (ABL) or Fecal Incontinence (FI) isn’t often talked about due to its embarrassing nature, but there are 20 million American women of all ages with this condition.    Accidental loss of stool is sometimes associated with an intense urge to rush to the bathroom.  It can also happen with no warning.  This condition particularly affects women who have experienced obstetric trauma from childbirth, or other nerve or muscle damage in the pelvic region.  Many women suffer in silence, fearing accidents and restricting their daily activities, not realizing that treatments exist which may help restore bowel control.  

LIBERATE is a research study for women experiencing bowel control problems. The study is evaluating the investigational Eclipse System, designed to provide immediate bowel control. The Eclipse System includes a vaginal insert and a hand-held pump for inflating and deflating a balloon on the insert.  The insert is placed in the vagina, resting in the same place as a diaphragm or tampon.  The insert is non-surgical and does not contain drugs or hormones. The Eclipse is designed to control the rectum from within the vagina in order to prevent accidental stool passage when the balloon is inflated. It may be removed at any time. 
The LIBERATE study involves longer-term follow-up than an earlier study, called LIFE, which followed women for 1-3 months of using the previous version of the Eclipse System.  The LIFE study found that most women experienced a reduction in accidents without major side effects and adverse events were mild or moderate, and none required any significant intervention.  The version of the Eclipse System used in the LIFE study was cleared by the U.S. Food and Drug Administration (FDA), but has not been commercially released by the company. The LIBERATE study is evaluating the next generation of Eclipse.

LIBERATE study participation may last approximately 15 months.  Some reimbursement is provided to study participants. 

Eligibility


Inclusion Criteria: 

  • Female Gender
  • At least 19 years old
  • History of accidental bowel leakage for at least 6 months

Principal Investigator


Physician Name: Dr. Uduak Umoh Andy
Affiliation: Univerisity of Pennsylvania

For information or patient referral contact


Study Coordinator: Lorraine Flick
Phone Number: 215-615-6569

 

Clinical Trials Now Recruiting!

Active Clinical Trials

Fertility and the BRCA gene

Studies on the Epigenetic Regulation of Human Pregnancy in  Fertile and Infertile Couples and Placental Parameters Sub-Study

Infertility

Paid research study seeking healthy women who are not at risk for pregnancy

Infertility study

Comparative Effectiveness of Pregnancy Failure Management Regimes